Do radiation oncologists and urologists endorse decision aids for active surveillance of low-risk prostate cancer: Results from a national survey.

Kang PuneetJon C TilburtRobert J VolkCharles L BennettZaina QureshiBoris GershmanHillary M SedlacekSimon P Kim

Published in: European journal of cancer care (2020)

Most specialists view DAs as effective tools to facilitate more informed treatment decisions and facilitate greater use of AS in appropriately selected patients.

Keyphrases

prostate cancer
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
rheumatoid arthritis
palliative care
systemic lupus erythematosus
decision making
radiation induced
advanced cancer